Method of determining functional estrogen receptors for prognosi

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 71, 435 721, 435 723, 435962, 436501, 436504, 436514, 436516, 436 63, 436 64, 436813, 436824, 2041828, C12Q 168, G01N 33574, G01N 33561

Patent

active

052926389

ABSTRACT:
A method and assay for determination of functionality of steroid receptors present in breast or other tumors. The method is useful for determination of cancer responsiveness to hormonal therapy by establishing a correlation between functioning estrogen receptors and those which are dysfunctional or nonfunctional. The assay is useful for determination whether the cancer, particularly the breast cancer, will respond to anti-estrogen hormonal therapy.

REFERENCES:
Klein-Hitpass, L., et al., Mol. Cell. Biol., vol. 9, No. 1, pp. 43-49 (Jan. 1989).
Murdoch, F. E., et al., Biochemistry, vol. 29, pp. 8377-8385 (Sep. 1990).
Peale, F. V., et al., Biochemistry, vol. 28, No. 22, pp. 8671-8675 (Oct. 31, 1989).
Hoehn, J. L., et al., Biological Abstracts, vol. 69, No. 3, The Abstract No. 18110, (Feb. 1980).
C. C. Benz, G. K. Scott, Abstract: Can. Gel-shift Assays Detect Hormone Resistant ER-Positive Breast Cancers?, Breast Cancer Res. Treat., 14:178 (1989), Editor W. L. McGuire, Kluwer Academic Publishers.
V. Kumar, P. Chambron, The Estrogen Receptor Binds Tightly to its Responsive Element as a Ligand-Induced Homodimer Cell, 55:145 (1988).
F. Keeman, UCSF Specialist Questions Therapy for Breast Cancer, San Francisco Examiner, A-16 Tuesday, Mar. 27, 1990.
Associated Press, Soybeans May Prevent Breast Cancer, A5, Marin Independent Journal, Tuesday, Mar. 27, 1990.
R. Knox, Odds of Breast Cancer Relapse May be Misstated, Scientist Says, Boston Globe, Mar. 26, 1990.
T. Friend, Other Promising Research, USA Today-Life, Mar. 27, 1990.
G. Scott, P. Kushner, J. L. Vigne, and C. Benz, J. Clin. Invest., Truncated Forms of DNA-binding Estrogen Receptors in Human Breast Cancer, Journal of Clinical Investigation, Inc., vol. 88, 700-706, (Aug. 1991).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of determining functional estrogen receptors for prognosi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of determining functional estrogen receptors for prognosi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining functional estrogen receptors for prognosi will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-152492

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.